| Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses SR Lockhart, KA Etienne, S Vallabhaneni, J Farooqi, A Chowdhary, ... Clinical Infectious Diseases 64 (2), 134-140, 2017 | 1393 | 2017 |
| Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species SG Whaley, EL Berkow, JM Rybak, AT Nishimoto, KS Barker, PD Rogers Frontiers in microbiology 7, 231851, 2017 | 818 | 2017 |
| Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus—United States, May 2013–August 2016 S Vallabhaneni MMWR. Morbidity and mortality weekly report 65, 2016 | 478 | 2016 |
| Fluconazole resistance in Candida species: a current perspective EL Berkow, SR Lockhart Infection and drug resistance, 237-245, 2017 | 467 | 2017 |
| Changes in the epidemiological landscape of invasive candidiasis F Lamoth, SR Lockhart, EL Berkow, T Calandra Journal of Antimicrobial Chemotherapy 73 (suppl_1), i4-i13, 2018 | 457 | 2018 |
| Candida auris: The recent emergence of a multidrug-resistant fungal pathogen K Forsberg, K Woodworth, M Walters, EL Berkow, B Jackson, T Chiller, ... Medical mycology 57 (1), 1-12, 2019 | 354 | 2019 |
| Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species JF Muñoz, L Gade, NA Chow, VN Loparev, P Juieng, EL Berkow, ... Nature communications 9 (1), 5346, 2018 | 335 | 2018 |
| Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans SA Flowers, KS Barker, EL Berkow, G Toner, SG Chadwick, SE Gygax, ... Eukaryotic cell 11 (10), 1289-1299, 2012 | 253 | 2012 |
| Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses NA Chow, JF Muñoz, L Gade, EL Berkow, X Li, RM Welsh, K Forsberg, ... MBio 11 (2), 10.1128/mbio. 03364-19, 2020 | 235 | 2020 |
| Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey NA Chow, L Gade, SV Tsay, K Forsberg, JA Greenko, KL Southwick, ... The Lancet Infectious Diseases 18 (12), 1377-1384, 2018 | 229 | 2018 |
| Antifungal susceptibility testing: current approaches EL Berkow, SR Lockhart, L Ostrosky-Zeichner Clinical Microbiology Reviews 33 (3), 10.1128/cmr. 00069-19, 2020 | 199 | 2020 |
| Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance P Escandón, NA Chow, DH Caceres, L Gade, EL Berkow, P Armstrong, ... Clinical Infectious Diseases 68 (1), 15-21, 2019 | 197 | 2019 |
| Epidemiological cutoff values for antifungal susceptibility testing GW Procop, PJ Dufresne, E Berkow, M Castanheira, J Fuller, KE Hanson, ... (No Title), 2020 | 193 | 2020 |
| Notes from the field: ongoing transmission of Candida auris in health care facilities—United States, June 2016–May 2017 S Tsay MMWR. Morbidity and mortality weekly report 66, 2017 | 183 | 2017 |
| Population-based active surveillance for culture-confirmed candidemia—four sites, United States, 2012–2016 M Toda MMWR. Surveillance Summaries 68, 2019 | 177 | 2019 |
| Candida auris isolates resistant to three classes of antifungal medications—New York, 2019 B Ostrowsky MMWR. Morbidity and mortality weekly report 69, 2020 | 166 | 2020 |
| Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris JM Rybak, JF Muñoz, KS Barker, JE Parker, BD Esquivel, EL Berkow, ... MBio 11 (3), 10.1128/mbio. 00365-20, 2020 | 105 | 2020 |
| Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris EL Berkow, SR Lockhart Diagnostic microbiology and infectious disease 90 (3), 196-197, 2018 | 103 | 2018 |
| Isolation of Candida auris from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing AB Araúz, DH Caceres, E Santiago, P Armstrong, S Arosemena, C Ramos, ... Mycoses 61 (1), 44-47, 2018 | 100 | 2018 |
| In Vitro Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida auris EL Berkow, D Angulo, SR Lockhart Antimicrobial agents and chemotherapy 61 (7), 10.1128/aac. 00435-17, 2017 | 99 | 2017 |
